Lynx1 Capital Management LP

Lynx1 Capital Management LP is listed in filings as 10% Owner at Korro Bio, Inc.. This profile follows SEC Form 4 activity through Apr 2, 2026, including purchase activity. Recent filings connect the profile to Korro Bio, Inc. (KRRO), TScan Therapeutics, Inc. (TCRX), Cullinan Therapeutics, Inc. (CGEM), and Passage Bio, Inc. (PASG). The current snapshot covers public activity from Nov 19, 2024 to Apr 2, 2026. Reported amounts are shown as $5.5K to $68.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.